Literature DB >> 29305712

Central Lymph Node Metastasis in Papillary Thyroid Carcinoma.

Ashok R Shaha1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29305712     DOI： 10.1007/s00268-017-4459-8

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  6 in total

1.  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Steven I Sherman; R Michael Tuttle
Journal:  Thyroid       Date:  2006-02       Impact factor: 6.568

2.  Does failure to perform prophylactic level VI node dissection leave persistent disease detectable by ultrasonography in patients with low-risk papillary carcinoma of the thyroid?

Authors:  Jack M Monchik; Caroline J Simon; Diana L Caragacianu; Alan A Thomay; Vicki Tsai; Jonah Cohen; Peter J Mazzaglia
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

3.  Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection.

Authors:  I J Nixon; L Y Wang; I Ganly; S G Patel; L G Morris; J C Migliacci; R M Tuttle; J P Shah; A R Shaha
Journal:  Br J Surg       Date:  2015-10-29       Impact factor: 6.939

Review 4.  Clinical risk factors for central lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis.

Authors:  Hui Qu; Guo-rui Sun; Yao Liu; Qing-si He
Journal:  Clin Endocrinol (Oxf)       Date:  2014-09-22       Impact factor: 3.478

Review 5.  The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis.

Authors:  Liang-Sen Liu; Jia Liang; Jun-Hong Li; Xue Liu; Li Jiang; Jian-Xiong Long; Yue-Ming Jiang; Zhi-Xiao Wei
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-19       Impact factor: 2.503

6.  Risk Factors for Central Neck Lymph Node Metastases in Micro- Versus Macro- Clinically Node Negative Papillary Thyroid Carcinoma.

Authors:  Luca Sessa; Celestino Pio Lombardi; Carmela De Crea; Serena Elisa Tempera; Rocco Bellantone; Marco Raffaelli
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352
  6 in total
  3 in total

1.  Risk Factors That Influence Surgical Decision-Making for Patients with Low-Risk Differentiated Thyroid Cancer with Tumor Diameters of 1-4 cm.

Authors:  Xiangming Wang; Chao Zhang; Wenbin Yu; Akanksha Srivastava; Chuan Liu; Dongmin Wei; Yuncheng Li; Jianming Yang
Journal:  Cancer Manag Res       Date:  2020-12-02       Impact factor: 3.989

2.  Using Diffusion-Weighted MRI to Predict Central Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Feasibility Study.

Authors:  Heng Zhang; Shudong Hu; Xian Wang; Wenhua Liu; Junlin He; Zongqiong Sun; Yuxi Ge; Weiqiang Dou
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-12       Impact factor: 5.555

3.  Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma.

Authors:  Wenchao Xu; Fulian Chen; Xiao Fei; Xiaoqing Yang; Xiaofei Lu
Journal:  Med Sci Monit       Date:  2018-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.